ANGPTL3 and ANGPTL8 in Thai subjects with hyperalphalipoproteinemia and severe hypertriglyceridemia

Background: The role of ANGPTL3 and ANGPTL8 in lipid regulation in patients with very high levels of HDL-cholesterol and triglyceride is unknown. Objective: We examined plasma levels of ANGPTL3 and ANGPTL8 in subjects with hyperalphalipoproteinemia (HALP) and in those with severe hypertriglyceridemia (HTG). Methods: Plasma ANGPTL3 and ANGPTL8 levels were measured by ELISA in 320 subjects, consisting of HALP subjects with HDL-cholesterol >100 mg/dl (n = 90) and healthy controls (n = 90) and subjects with triglyceride >886 mg/dl (n = 89) and control subjects (n = 51). Results: The mean plasma ANGPTL3 level was significantly higher in the HALP group compared to that of the controls (297 +/- 112 ng/mL vs. 230 +/- 100 ng/mL, p < 0.001). Similarly, the mean plasma ANGPTL8 level was also higher in the HALP group (30 +/- 11 ng/mL vs. 20 +/- 8 ng/mL, p < 0.001). Both ANGPTL3 and ANGPTL8 levels positively correlated with HDL-cholesterol levels. In the severe HTG group, plasma ANGPTL3 level was significantly higher than those in the control group (223 +/- 105 ng/mL vs. 151 +/- 60 ng/mL, p < 0.001), but not ANGPTL8 (23 +/- 20 ng/mL vs. 31 +/- 23 ng/mL in controls, p = 0.028). Only ANGPTL3, but not ANGPTL8, levels positively correlated with triglyceride levels. Conclusion: Plasma level of ANGPTL3 was increased in both HALP and severe HTG whereas an increase in plasma level of ANGPTL8 was found only in HALP, and not in severe HTG, suggesting that both ANGPTL3 and ANGPTL8 might play distinct roles in lipid regulation on these two extremes of dyslipidemia. (c) 2021 National Lipid Association. Published by Elsevier Inc. All rights reserved.